Individual results vary based on genetics, lifestyle adherence, starting weight, and dose escalation
ACT 2: The Regulatory Pipeline What's Actually Close to Approval Excitement about clinical trial data needs to be tempered by one practical reality: a Phase 2 result is not a prescription you can fill at a pharmacy today
Fiorentino M, Bolignano D, Tesar V, Pisano A, Biesen WV, Tripepi G, et al
Clinical studies show that many patients using GLP-1 medications such as semaglutide or tirzepatide may lose a meaningful percentage of body weight over time when combined with lifestyle changes
Patients might experience nausea, vomiting and even diarrhea
A licensed provider will complete a medical evaluation to determine if treatment is appropriate